|
|
| (4 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| {{Aortic stenosis}}
| |
| {{CMG}}
| |
|
| |
|
| '''Associate Editors-In-Chief:''' Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu]; [[User:Abdarabi|Abdul-Rahman Arabi, M.D.]] [mailto:abdarabi@yahoo.com]; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; [[Priyamvada Singh|Priyamvada Singh, MBBS]] [[mailto:psingh@perfuse.org]]
| |
|
| |
| '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@perfuse.org]]
| |
|
| |
| ==Overview==
| |
| Surgical intervention may be a necessary component of treatment. Intervention methods may include mechanical and device based therapies such as bileaflet mechanical aortic valves.
| |
|
| |
| ==Aortic stenosis surgery devices|Mechanical and Device Based Therapy==
| |
| Aortic stenosis requires [[aortic valve replacement]] if medical management does not successfully control symptoms.
| |
| According to a prospective, single-center, nonrandomized study of 25 patients, percutaneous implantation of an aortic valve prosthesis in high risk patients with aortic stenosis results in marked hemodynamic and clinical improvement when successfully completed.<ref>{{cite journal |author=Grube E, Laborde JC, Gerckens U, ''et al'' |title=Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study |journal=Circulation |volume=114 |issue=15 |pages=1616-24 |year=2006 |pmid=17015786 |doi=10.1161/CIRCULATIONAHA.106.639450}}</ref>
| |
|
| |
| *Bileaflet Mechanical Aortic Valve
| |
| <googlevideo>4541951625687665949&hl=en</googlevideo>
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| [[Category:DiseaseState]]
| |
| [[Category:Signs and symptoms]]
| |
| [[Category:Physical Examination]]
| |
| [[Category:Valvular heart disease]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Congenital heart disease]]
| |
|
| |
| {{WH}}
| |
| {{WS}}
| |